Weight Loss Isn’t the Whole Story in the GLP-1 Revolution
GLP-1s Have Reached a Tipping Point
GLP-1 medications have rapidly evolved from a niche treatment primarily associated with diabetes management into one of the most influential consumer health trends in America. Today, 39% of U.S. adults know someone who has taken or is currently taking a GLP-1, signaling how deeply these medications have penetrated mainstream culture. Even more striking, 14% of U.S. adults, representing approximately 38 million people, report that they have taken or are currently taking a GLP-1. Adoption is widespread across demographics; however, white men account for 37% of current GLP-1 users and white women make up another 36%. One particularly notable audience emerges among Gen X men, where 20% report taking a GLP-1, making them 38% more likely than the average adult to be users.
For marketers, these numbers reveal that GLP-1s are more than a healthcare trend. They represent a significant consumer segment whose behaviors, spending patterns, and media engagement are creating new opportunities across industries.
39% of U.S. adults know someone who has used a GLP-1, and 38 million Americans have taken one themselves.
Weight Loss Is the Catalyst, But Health Is the Broader Story
While weight loss dominates the conversation around GLP-1s, motivations for using these medications are more diverse than many assume.
- Among current users, 49% cite weight loss as their primary reason for taking a GLP-1.
- Another 40% say they are taking one to improve their overall health or metabolic health, demonstrating that wellness goals extend beyond the number on a scale.
- Over 1 in 3 (34%) are taking a GLP-1 for its intended medical purpose of managing diabetes or prediabetes, while 30% use them to control food cravings.
- Social influence also plays a role, with 11% saying their decision was influenced by family members, friends, influencers, or celebrities. In fact, GLP-1 users are 53% more likely to trust the advice of a social media influencer over advice from a healthcare provider.
These findings suggest that brands should move beyond simplistic "before and after" narratives and instead recognize the broader wellness aspirations driving adoption.
A closer look at the data reveals distinct motivations across demographic groups.
- Men taking GLP-1s are 69% more likely than average users to say they use the medication to reduce alcohol cravings or consumption, pointing to growing interest in GLP-1s as tools for behavior modification beyond weight loss.
- Men are also 32% more likely to cite influencers or celebrities as an influence on their decision to use the medication.
- Among Gen Z users, the story looks different, as they are 23% more likely to be taking a GLP-1 to manage diabetes or prediabetes.
- Meanwhile, Boomers taking a GLP-1 are 17% more likely than average users to be motivated by weight loss.
These differences highlight the need for audience-specific messaging strategies. The factors motivating a Gen Z user seeking metabolic health solutions may be very different from those driving a Boomer focused on weight management.
The Family Doctor Still Matters Most
Despite headlines about digital health startups and online prescription services, traditional healthcare channels remain the dominant pathway into GLP-1 treatment.
- 6 in 10 users received their prescription from their primary care provider, making physicians the most influential gatekeepers in the category.
- Another 11% received prescriptions from telehealth providers such as Ro or Sequence, while an additional 11% worked with specialists.
- Hospital-based weight management and bariatric programs account for 7% of prescriptions, and fewer than 3% obtained their medication through urgent care or retail clinics.
Gender differences also emerge in the patient journey.
- Men are 40% more likely to access GLP-1s through employer-sponsored or insurance programs, while women are 39% more likely to obtain them through telehealth services.
For healthcare marketers and pharmaceutical advertisers, these findings reinforce the importance of omnichannel strategies that address both traditional care environments and emerging digital pathways.
83% of GLP-1 users say the medication has changed how they live, spend, exercise, or shop.
GLP-1s Are Reshaping Everyday Consumer Behavior
Perhaps the most significant implication for brands is that GLP-1 usage is not an isolated healthcare decision. It is creating ripple effects that influence nearly every aspect of consumer behavior. Among those taking a GLP-1, 83% report making lifestyle changes since starting the medication.
- Nearly half (45%) say they are exercising more, while 34% are dining out less frequently.
- 30% report drinking less alcohol, and an equal share say they have needed to buy new clothes as their bodies change.
- Some lifestyle shifts extend even further, with 11% traveling more and 8% either pursuing or considering plastic surgery.
These changes illustrate that GLP-1 adoption often triggers a broader self-improvement journey, creating opportunities for brands across fitness, apparel, travel, food and beverage, and personal care categories.
The Next Wave of Growth Is Already Forming
Current GLP-1 consumers are only part of the story. Another 20% of U.S. adults, approximately 52 million people, are considering taking a GLP-1 for weight loss.
- Many are making lifestyle sacrifices, with 36% cutting back on dining out, 30% reducing clothing purchases, and 25% scaling back on events and travel.
- At the same time, financial pressure is driving ambition, as 30% are actively job hunting for higher pay, 62% higher than the average adult.
However, these pressures are also influencing financial decisions in ways that may have long-term implications.
- Of those, 17 million are actively considering it today, while 35 million say they would consider it in the future.
- This audience skews younger, with 37% between the ages of 18 and 34, 34% between 35 and 54, and 29% age 55 or older. In fact, 26% of adults aged 18 to 34 are considering taking a GLP-1.
- They are also highly engaged healthcare consumers: 84% have health insurance, 78% have a primary care provider, and 84% are the primary decision-maker for their own healthcare.
- Compared to average adults, they are 42% more likely to use retail health clinics and 27% more likely to use telehealth services.
- Notably, 54% are using AI tools to help guide healthcare decisions, creating new opportunities for healthcare brands to reach consumers through emerging digital touchpoints.
Perhaps the most compelling opportunity for marketers is that prospective GLP-1 consumers are both highly engaged and highly persuadable. Unlike many healthcare audiences, they are remarkably receptive to advertising and already have a positive perception of these medications.
- Of those, 17 million are actively considering it today, while 35 million say they would consider it in the future.
- Prospective users are overwhelmingly confident in their plan to take the medication, as 71% believe the benefits of GLP-1s far outweigh the risks.
- Prospective users are overwhelmingly confident in to just 33% of all adults. That confidence translates into a greater willingness to engage with healthcare marketing.
- Adults considering a GLP-1 are 49% more likely than average to find prescription drug advertising entertaining.
- They are 34% more likely to discuss a medication with their doctor after seeing or hearing an advertisement and 52% more likely to ultimately take a medication they see advertised.
This indicates a consumer group that is actively researching options, open to information, and willing to be influenced through media exposure. For pharmaceutical companies and agency planners, this represents a rare audience that combines high intent with a demonstrated openness to marketing influence, making educational, informative, and action-oriented messaging especially effective.
Market to the Lifestyle, Not Just the Medication
The rise of GLP-1s represents far more than a pharmaceutical trend. It is reshaping how millions of consumers eat, exercise, shop, travel, socialize, and manage their health. Current GLP-1 consumers are embracing lifestyle changes that touch multiple industries, while tens of millions more are considering joining them.
For brands, the biggest opportunity lies in recognizing that GLP-1 consumers are not simply pursuing weight loss. They are pursuing transformation, confidence, health, and self-improvement. Messaging that celebrates healthier lifestyles and acknowledges consumers' evolving identities will resonate with both current users and prospective adopters. As GLP-1 adoption continues to grow, the brands that win will be those that understand the medication is just the beginning of a much larger consumer journey.
Source: MRI-Simmons 2026 Health & Wellness Study (SP26 USA)
